We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+19.83%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$5.32B
AUM Growth
+$1.51B
Cap. Flow
+$1.01B
Cap. Flow %
18.97%
Top 10 Hldgs %
41.92%
Holding
164
New
62
Increased
26
Reduced
36
Closed
37

Top Buys

Rank Stock Value
1
RUN icon
Sunrun
RUN
+$145M
2
META icon
Meta Platforms (Facebook)
META
+$135M
3
COF icon
Capital One
COF
+$126M
4
NFLX icon
Netflix
NFLX
+$124M
5
BILL icon
BILL Holdings
BILL
+$115M

Top Sells

Rank Stock Value
1
BKNG icon
Booking.com
BKNG
+$143M
2
MA icon
Mastercard
MA
+$97.9M
3
CRM icon
Salesforce
CRM
+$83.6M
4
DD icon
DuPont de Nemours
DD
+$75.9M
5
UNH icon
UnitedHealth
UNH
+$73.4M

Sector Composition

Rank Sector Weight
1 Technology 33.16%
2 Consumer Discretionary 11.55%
3 Communication Services 9.21%
4 Healthcare 7.22%
5 Financials 5.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
76
Pfizer
PFE
$144B
$9.91M 0.19%
269,179
-392,248
-59% -$14.4M
AER icon
77
AerCap
AER
$23.9B
$9.8M 0.18%
+215,080
New +$7.51M
TMUS icon
78
T-Mobile US
TMUS
$195B
$9.54M 0.18%
+70,728
New +$8.74M
BIIB icon
79
CALL
Biogen
BIIB
$30.7B
$9.43M 0.18%
+38,500
New +$9.93M
HUM icon
80
Humana
HUM
$43.1B
$9.21M 0.17%
22,447
-173,944
-89% -$72.3M
CAH icon
81
Cardinal Health
CAH
$54.3B
$7.11M 0.13%
132,805
-166,549
-56% -$8.64M
XBI icon
82
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$7.04M 0.13%
+50,000
New +$6.4M
JNJ icon
83
Johnson & Johnson
JNJ
$643B
$6.8M 0.13%
43,200
-127,785
-75% -$18.9M
AZN icon
84
AstraZeneca
AZN
$269B
$6.75M 0.13%
+67,500
New +$7.15M
D icon
85
Dominion Energy
D
$62.1B
$5.99M 0.11%
+79,691
New +$6.33M
DVA icon
86
DaVita
DVA
$15.5B
$5.97M 0.11%
+50,878
New +$5.18M
GILD icon
87
CALL
Gilead Sciences
GILD
$167B
$5.83M 0.11%
+100,000
New +$6.03M
MDT icon
88
Medtronic
MDT
$113B
$5.78M 0.11%
49,300
-5,700
-10% -$627K
COR icon
89
Cencora
COR
$62.3B
$5.69M 0.11%
58,190
-31,234
-35% -$3.12M
ELV icon
90
Elevance Health
ELV
$81.8B
$5.39M 0.1%
16,791
-76,221
-82% -$23.4M
GILD icon
91
Gilead Sciences
GILD
$167B
$5.18M 0.1%
88,931
+6,431
+8% +$388K
BMRN icon
92
BioMarin Pharmaceuticals
BMRN
$11.9B
$5.18M 0.1%
59,042
-249,109
-81% -$19.7M
LH icon
93
Labcorp
LH
$25.5B
$5.06M 0.1%
28,920
-94,250
-77% -$16.3M
VTRS icon
94
Viatris
VTRS
$20.8B
$4.88M 0.09%
260,463
+49,463
+23% +$807K
BMY icon
95
Bristol-Myers Squibb
BMY
$130B
$4.77M 0.09%
+76,828
New +$4.72M
TDOC icon
96
Teladoc Health
TDOC
$1.68B
$4.5M 0.08%
22,500
+9,000
+67% +$1.83M
INTC icon
97
Intel
INTC
$425B
$4.48M 0.08%
+90,000
New +$4.4M
TMO icon
98
Thermo Fisher Scientific
TMO
$213B
$4.4M 0.08%
+9,450
New +$4.43M
LLY icon
99
CALL
Eli Lilly
LLY
$1.09T
$4.22M 0.08%
+25,000
New +$3.73M
FTV icon
100
Fortive
FTV
$18B
$4.13M 0.08%
77,367
-385,098
-83% -$19.8M
2 3
4
5 6

Similar funds

CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
IMRF
Illinois Municipal Retirement Fund Oak Brook, Illinois $7.86B AUM 24.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
CMTU
Capital Markets Trading (UK) London, United Kingdom $7.95B AUM 85.98% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
MT
Midwest Trust Overland Park, Kansas $8.02B AUM 23.54% 1-Year Est. Return

PointState Capital's Q4 2020 Portfolio in Review

As of Q4 2020, PointState Capital held 164 positions worth $5.32B, up 40% from $3.81B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

PointState Capital deployed $1.01B of net new capital in Q4 2020, opening 62 new positions and adding to 26 existing holdings. Its largest new stake was Sunrun: 2,339,797 shares worth $162M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Booking.com, an estimated $143M trimmed.

  • PointState Capital's largest Q4 2020 buy was Sunrun: 2,339,797 shares worth $162M.
  • PointState Capital added most to Capital One in Q4 2020, an estimated $126M increase.
  • PointState Capital's biggest Q4 2020 reduction was Booking.com, cutting an estimated $143M.
  • PointState Capital fully exited DuPont de Nemours in Q4 2020, selling an estimated $75.9M.
  • PointState Capital's ten largest holdings make up 42% of its $5.32B portfolio in Q4 2020.
  • PointState Capital opened 62 new positions and closed 37 in Q4 2020.
  • PointState Capital's portfolio value rose 40% quarter-over-quarter to $5.32B.

Based on PointState Capital's 13F filing for Q4 2020, filed 16 Feb 2021.